1. Home
  2. CCS vs DNTH Comparison

CCS vs DNTH Comparison

Compare CCS & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

N/A

Current Price

$57.79

Market Cap

1.7B

ML Signal

N/A

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

N/A

Current Price

$78.91

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCS
DNTH
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
CCS
DNTH
Price
$57.79
$78.91
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$70.50
$123.09
AVG Volume (30 Days)
206.8K
1.1M
Earning Date
04-22-2026
03-09-2026
Dividend Yield
2.08%
N/A
EPS Growth
N/A
N/A
EPS
4.86
N/A
Revenue
$4,117,816,000.00
$2,036,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$10.84
$30.33
P/E Ratio
$11.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.42
$13.37
52 Week High
$76.00
$88.45

Technical Indicators

Market Signals
Indicator
CCS
DNTH
Relative Strength Index (RSI) 34.89 67.84
Support Level $56.72 $33.94
Resistance Level $66.17 $88.45
Average True Range (ATR) 1.77 4.88
MACD -0.26 -0.13
Stochastic Oscillator 32.73 68.24

Price Performance

Historical Comparison
CCS
DNTH

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: